A reorientation of the original Flux (Following Lives Undergoing Change) Study, this report summarises baseline data collected from 913 gay and bisexual men (GBM) during April 2020 on the impacts of COVID-19 and physical distancing measures. We reported findings on sexual behaviours, use of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), drug use, mental health, testing for COVID-19 and social connectedness among GBM in Australia in the early stages of the pandemic.
Australia has been a world leader in research and surveillance documenting the impact of control programs for cervical cancer. C4 Partners include many investigators who have been collecting, analysing, and reporting key epidemiological information about the occurrence of cervical cancer and its precursors. The resources of C4 and its partner organisations have been used in consultation with key stakeholders to deliver this comprehensive report.
The Gaps Project Report synthesises multiple data sources to identify emerging HIV prevention gaps in various subpopulations of gay, bisexual, and other men who have sex with men (GBMSM) in Australia between 2009–2018. This includes HIV diagnoses data from the National HIV Registry, clinical data from the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood Borne Viruses and Sexually Transmissible Infections (ACCESS), and behavioural data from the Gay Community Periodic Surveys (GCPS).
Australia is aiming to eliminate hepatitis C as a public health threat by 2030. This elimination goal is in line with global targets set by the World Health Organization (WHO) and targets included in Australia’s National Hepatitis C Strategy 2018–2022.
Prepared by Burnet Institute and the Kirby Institute, this report brings together national data sources to assess Australia’s progress towards eliminating hepatitis C. Some data were not included due to unavailability at the time of reporting; future reports will provide the most comprehensive picture possible.
This report provides an overview of data HIV diagnoses in heterosexual people, Aboriginal and Torres Strait Islander people, and people who inject drugs in NSW during the NSW HIV Strategy 2016-2020, with analyses based on data available between 2013 and 2019.
This report provides a detailed overview of trends in HIV diagnoses and HIV prevention indicators in gay, bisexual and other men who have sex with men (GBMSM) during the NSW HIV Strategy 2016-2020, with analyses based on data available to the end of 2019.
This report presents the findings of an evaluation of a[TEST], a community-based HIV/STI testing service targeted at gay and bisexual men in NSW. This evaluation aimed to assess the effectiveness of the service in reaching priority populations, determine the number of HIV notifications captured by the service, and assess client satisfaction of the service. The contribution of a[TEST] to HIV prevention in NSW was also assessed.
This report summarises key findings from mathematical modelling undertaken in 2018–2019 to provide insight into the infectious syphilis outbreak in Indigenous Australians occurring in regional and remote areas of Queensland, Northern Territory, South Australia and Western Australia. The research was undertaken by the Kirby Institute, UNSW Sydney, for the Multi-jurisdictional Syphilis Outbreak (MJSO) Working Group with funding from the Australian Department of Health.
The INTO? study was a cross-sectional survey of gay and bisexual men (GBM) in Australia conducted between December 2019 and March 2020. INTO? examined recent sexual and drug use events, with a focus on how biomedical HIV prevention methods may affect the negotiation of sex and drug use practices. Focusing on specific events rather than behaviour over a period of time can be useful to understand the complexities and specifics of intentions, behaviours, and disclosure of HIV status as individuals negotiate sex with different partners.
This is a report on the findings from the PrEP in NSW Transition Study. Over the period August 2018 to March 2020, 2,344 people who had been offered HIV pre-exposure prophylaxis (PrEP) as part of the Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) trial agreed to be followed-up for a further 12 months as part of the PrEP in NSW Transition Study.